This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Jiangsu Hansoh Pharmaceutical Group Co., Ltd.. Active years: 2017-2020.
Location History:
- Lianyungang, CN (2017)
- Jiangsu, CN (2019 - 2020)
Company Filing History:
Years Active: 2017-2020
Certainly! Here is the article about inventor Jun Yu:
Title: Unveiling the Innovations of Jun Yu from Jiangsu, China
Introduction:
Jun Yu, an inventive mind hailing from Jiangsu, China, has made remarkable contributions in the field of pharmaceuticals with his ingenuity and dedication.
Latest Patents:
1. Crystal form of dapagliflozin intermediate and preparation method therefor: Jun Yu's recent patent unveils a crystal form of a dapagliflozin intermediate, enhancing the purity to over 99.3% and simplifying the industrial production process.
2. Dapagliflozin crystal form and preparation method and use thereof: Another notable invention includes a new crystal form of dapagliflozin, along with a method for preparation and therapeutic use in treating type II diabetes.
Career Highlights:
Jun Yu is a valued member of Jiangsu Hansoh Pharmaceutical Group Co., Ltd., where his innovative spirit thrives, contributing significantly to the advancement of pharmaceutical technology.
Collaborations:
Throughout his career, Jun Yu has collaborated closely with colleagues like Xiang Li and Jinjia Wang, synergizing their collective expertise to achieve groundbreaking innovations in pharmaceutical research.
Conclusion:
Jun Yu's groundbreaking patents and collaborative efforts underscore his pivotal role in pushing the boundaries of pharmaceutical innovation, solidifying his legacy as a visionary inventor in the industry.